Invention Grant
- Patent Title: IDO inhibitors
-
Application No.: US15737798Application Date: 2016-06-27
-
Publication No.: US10689331B2Publication Date: 2020-06-23
- Inventor: James Aaron Balog , Emily Charlotte Cherney , Jay A. Markwalder , Weifang Shan , David K. Williams
- Applicant: Bristol-Myers Squibb Company
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agency: BakerHostetler
- International Application: PCT/US2016/039564 WO 20160627
- International Announcement: WO2016/210414 WO 20161229
- Main IPC: A61K31/18
- IPC: A61K31/18 ; A61K31/196 ; A61K31/381 ; A61K31/404 ; A61K31/41 ; A61K31/42 ; A61K31/421 ; A61K31/426 ; A61K31/433 ; A61K31/4406 ; A61K31/505 ; A61K31/513 ; C07C275/42 ; C07D239/42 ; C07D261/14 ; C07D285/12 ; C07C311/51 ; C07C311/49 ; C07C275/40 ; C07C233/44 ; A61K45/06 ; C07C311/46 ; C07D209/08 ; C07D213/72 ; C07D239/47 ; C07D257/04 ; C07D263/32 ; C07D277/38 ; C07D285/135 ; C07D333/34
Abstract:
There are disclosed compounds that modulate or inhibit the enzymatic activity of indoleamine 2,3-dioxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, viral infections and/or inflammatory disorders utilizing the compounds of the invention.
Public/Granted literature
- US20190002402A1 IDO INHIBITORS Public/Granted day:2019-01-03
Information query
